Trial Profile
Phase I Dose Escalation Trial of External Beam Radiation and Cyberknife Radiosurgery Boost With Concurrent Capecitabine for Hilar Cholangiocarcinoma (Klatskin Tumor)
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Cholangiocarcinoma
- Focus Adverse reactions
- 09 Apr 2011 New trial record